Skip to main content

Table 2 Summary of outcomes used as primary endpoint

From: Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: A meta-analysis of randomized controlled trials

Study

Recurrence Rate %

Survival %

 

1 yr

2 yr

3 yr

1 yr

2 yr

3 yr

Mizuta et al.

Treatment

12.5

39

64.3

100

96.6

87

Control

55.2

83.2

91.6

96.4

80.9

64

Kakizaki et al.

Treatment

7.7

51.4

61.2

100

95

77.5

Control

55.2

83.2

91.6

95.8

90.2

66.4

Hotta et al.

Treatment

23.8

28.6

-

100

100

-

Control

33.3

46.5

73.3

87.5

81.7

81.7

Yoshiji et al.

Treatment

22

44

61

100

94.4

88.9

Control

24

48

68

100

92

88

Yoshida et al.

Treatment

28.2

-

-

97.2

-

-

Control

34.5

-

-

99.0

-

-

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us